Alexandria Real Estate Equities, Inc. Announces Dual Listing on NYSE Texas, Reinforcing Its Strategic Commitment to Texas

PR Newswire

PASADENA, Calif., Nov. 16, 2026

PASADENA, Calif., Nov. 16, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science and advanced technology innovation cluster locations, today announced the dual listing of its common stock on NYSE Texas, Inc. (NYSE Texas), the fully electronic equities exchange headquartered in Dallas, effective November 17, 2026. Alexandria will maintain its primary listing on the New York Stock Exchange (NYSE) and trade under its existing "ARE" ticker symbol on both NYSE and NYSE Texas.

"Alexandria's dual listing on NYSE Texas represents a natural extension of our longstanding relationship with the New York Stock Exchange and our continued investment in life science and advanced technology innovation across Texas," said Joel S. Marcus, executive chairman and founder of Alexandria Real Estate Equities, Inc./Alexandria Venture Investments. "For more than three decades, Alexandria has helped catalyze and strengthen the most consequential life science and advanced technology innovation clusters, where world-class talent, leading academic and research institutions and strategic capital converge. Texas has emerged as an increasingly important center for advanced technology, and we are proud to further align our commitment to the state with NYSE Texas. Our Dallas regional office is located at the iconic Old Parkland, which is also home to the headquarters of NYSE Texas."

"We are pleased to welcome Alexandria Real Estate Equities to NYSE Texas," said Bryan Daniel, president of NYSE Texas. "Alexandria's campuses and venture investments are helping Texas life science and advanced technology innovation grow, and we look forward to supporting the company as it deepens its roots in the state."

The dual listing on NYSE Texas reinforces the company's strategic commitment to catalyzing life science and advanced technology innovation across Dallas, Greater Houston and Austin. In Greater Houston, the Alexandria Center® for Advanced Technologies at The Woodlands represents the company's mission-critical development of a commercial life science ecosystem at the intersection of biology and technology. The one-of-a-kind, multi-tenant collaborative campus is purpose-built to enable life science and advanced technology companies to scale in proximity to leading scientific, medical and academic institutions.

Alexandria's Intersection Campus is the premier advanced technology campus in Northeast Austin, underscoring the city's highly competitive and rapidly growing leadership in the industry. The region's deep concentration of world-class technology talent, leading research institutions and entrepreneurial companies has positioned Austin at the forefront of semiconductors, artificial intelligence, software, quantum computing, robotics, biotechnology, defense technology and other advanced technologies increasingly converging with life science to transform scientific discovery, drug development and human health. Intersection Campus tenant Natera, a global leader in cell-free DNA and precision medicine, exemplifies this convergence, leveraging advanced molecular biology, bioinformatics and artificial intelligence to advance personalized genetic testing and diagnostics across oncology, women's health and organ health.

Alexandria Venture Investments (AVI), the company's strategic venture capital platform and one of the most active early-stage life science investors in the United States, provides strategic risk capital to disruptive companies within Texas at the intersection of life science and advanced technology. Houston-based AVI portfolio company CrossBridge Bio represents a recent example of increasing strategic capital investment in biotechnology leading to large-scale pharma interest and exits within the region. CrossBridge Bio is pioneering next-generation dual-payload antibody-drug conjugates for the treatment of cancer, utilizing technology translated from UTHealth Houston. In April 2026, CrossBridge Bio entered into an agreement to be acquired by Eli Lilly for consideration of up to $300 million, reflecting the growing strength of the region's life science ecosystem and its ability to translate leading academic research into innovative companies and technologies with the potential to advance human health.

Alexandria's commitment to the region also extends through its longstanding mission-critical partnership with and support of the National Medal of Honor Museum Foundation, which opened the first-and-only museum dedicated to Medal of Honor Recipients in Arlington, Texas, in March 2025. Guided by its strategic corporate responsibility initiatives and deep commitment to advancing organizations that strengthen communities, inspire leadership and create lasting societal impact, Alexandria has proudly supported the Foundation for years, and Mr. Marcus has served on its board of directors since 2020. Alexandria's support was instrumental in advancing the Foundation's vision to create a permanent national tribute to the extraordinary Americans whose courage, sacrifice and service embody the values of character, integrity and purpose.

About Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. Founded in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator and developer of collaborative Megacampus™ ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City. For more information, please visit www.are.com.

Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding the anticipated benefits of Alexandria's dual listing on NYSE Texas; Alexandria's strategy and activities in Texas, including the expected benefits of its properties and venture investments; and the anticipated benefits and impact of its support for tenants, innovation and corporate responsibility initiatives. These forward-looking statements are based on Alexandria's present intent, beliefs or expectations, but are not guaranteed to occur. Actual results may differ materially from those expressed or implied due to a variety of factors, including the risks and uncertainties detailed in Alexandria's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and any subsequently filed Quarterly Reports on Form 10-Q. All forward-looking statements are made as of the date of this press release, and Alexandria assumes no obligation to update them, except as required by law.

CONTACT: Sara Cohen, Assistant Vice President – Capital Markets & Corporate Operations, (646) 799-2617, scohen@are.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-announces-dual-listing-on-nyse-texas-reinforcing-its-strategic-commitment-to-texas-302939241.html

SOURCE Alexandria Real Estate Equities, Inc.